The relationship between genetic polymorphism of ZNF804A and drug efficacy to schizophrenia: a meta-analysis
10.3760/cma.j.issn.1674-6554.2012.10.010
- VernacularTitle:锌指蛋白804A基因多态性与精神分裂症及其药物疗效关系的Meta分析
- Author:
Shuai WANG
;
Wenqiang LI
;
Hongxing ZHANG
;
Jingyuan ZHAO
;
Luxian LV
- Publication Type:Journal Article
- Keywords:
ZNF804A;
Gene polymorphism;
Schizophrenia;
Efficacy;
Meta-analysis
- From:
Chinese Journal of Behavioral Medicine and Brain Science
2012;21(10):897-899
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo assess the association of rs1344706 and rs4667001 polymorphism of ZNF804A gene with schizophrenia,and the relationship between rs1344706 polymorphism and antipsychotic drug efficacy.MethodsThe studies concerning association of ZNF804A gene polymorphism with schizophrenia and its drug efficacy were retrieved in databases such as Medline and CNKI,and then screened according to the inclusion and exclusion criteria.Meta-analysis was performed by RevMan 5.1 following quality assessment and data extraction.ResultsEleven high-quality studies under the criteria were included.For rs1344706,T allele frequency was significant higher in the schizophrenia group than control group ( OR=1.13,95％ CI (1.06-1.21 ),P=0.0003).Moreover,for rs4667001,G allele frequency was significant higher in the schizophrenia group ( OR =1.14,95％ CI( 1.04-1.26),P =0.005 ).In addition,the difference of PANSS scores reduction between T allele and GG genotype carriers was not significant in both positive and negative symptoms after four-week treatment,and the same trend of difference was in the comparison between TT genotype and G allele carriers.ConclusionThe data supports that T allele of rs1344706 and G allele of rs4667001 in ZNF804A gene are associated with the susceptibility of schizophrenia,but rs1344706 polymorphism is not related to antipsychotic drug efficacy.
